226 related articles for article (PubMed ID: 14708030)
1. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium.
Knable MB; Barci BM; Webster MJ; Meador-Woodruff J; Torrey EF;
Mol Psychiatry; 2004 Jun; 9(6):609-20, 544. PubMed ID: 14708030
[TBL] [Abstract][Full Text] [Related]
2. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.
Tian SY; Wang JF; Bezchlibnyk YB; Young LT
Neurosci Lett; 2007 Jan; 411(2):123-7. PubMed ID: 17095155
[TBL] [Abstract][Full Text] [Related]
4. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
Uezato A; Meador-Woodruff JH; McCullumsmith RE
Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996
[TBL] [Abstract][Full Text] [Related]
5. Neural stem cell proliferation is decreased in schizophrenia, but not in depression.
Reif A; Fritzen S; Finger M; Strobel A; Lauer M; Schmitt A; Lesch KP
Mol Psychiatry; 2006 May; 11(5):514-22. PubMed ID: 16415915
[TBL] [Abstract][Full Text] [Related]
6. Neuropathology markers and pathways associated with molecular targets for antipsychotic drugs in postmortem brain tissues: exploration of drug targets through the Stanley Neuropathology Integrative Database.
Kim S; Zavitsanou K; Gurguis G; Webster MJ
Eur Neuropsychopharmacol; 2012 Oct; 22(10):683-94. PubMed ID: 22356822
[TBL] [Abstract][Full Text] [Related]
7. SNAP-25 reduction in the hippocampus of patients with schizophrenia.
Thompson PM; Egbufoama S; Vawter MP
Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):411-7. PubMed ID: 12691775
[TBL] [Abstract][Full Text] [Related]
8. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
Beneyto M; Meador-Woodruff JH
Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238
[TBL] [Abstract][Full Text] [Related]
9. Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers.
Knable MB; Barci BM; Bartko JJ; Webster MJ; Torrey EF
Mol Psychiatry; 2002; 7(4):392-404. PubMed ID: 11986983
[TBL] [Abstract][Full Text] [Related]
10. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia.
Vawter MP; Thatcher L; Usen N; Hyde TM; Kleinman JE; Freed WJ
Mol Psychiatry; 2002; 7(6):571-8. PubMed ID: 12140780
[TBL] [Abstract][Full Text] [Related]
11. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
Webster MJ; O'Grady J; Kleinman JE; Weickert CS
Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: a pilot study.
Strasser HC; Lilyestrom J; Ashby ER; Honeycutt NA; Schretlen DJ; Pulver AE; Hopkins RO; Depaulo JR; Potash JB; Schweizer B; Yates KO; Kurian E; Barta PE; Pearlson GD
Biol Psychiatry; 2005 Mar; 57(6):633-9. PubMed ID: 15780850
[TBL] [Abstract][Full Text] [Related]
13. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression.
Fatemi SH; Earle JA; McMenomy T
Mol Psychiatry; 2000 Nov; 5(6):654-63, 571. PubMed ID: 11126396
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.
Sawada K; Barr AM; Nakamura M; Arima K; Young CE; Dwork AJ; Falkai P; Phillips AG; Honer WG
Arch Gen Psychiatry; 2005 Mar; 62(3):263-72. PubMed ID: 15753239
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
16. Glial cell number and neuron/glial cell ratios in postmortem brains of bipolar individuals.
Brauch RA; Adnan El-Masri M; Parker JC; El-Mallakh RS
J Affect Disord; 2006 Mar; 91(1):87-90. PubMed ID: 16469390
[TBL] [Abstract][Full Text] [Related]
17. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs.
Eastwood SL; Harrison PJ
Mol Psychiatry; 2000 Jul; 5(4):425-32. PubMed ID: 10889554
[TBL] [Abstract][Full Text] [Related]
19. A rodent model of schizophrenia derived from postmortem studies.
Berretta S; Gisabella B; Benes FM
Behav Brain Res; 2009 Dec; 204(2):363-8. PubMed ID: 19539659
[TBL] [Abstract][Full Text] [Related]
20. A novel population of calretinin-positive neurons comprises reelin-positive Cajal-Retzius cells in the hippocampal formation of the adult domestic pig.
Abrahám H; Tóth Z; Seress L
Hippocampus; 2004; 14(3):385-401. PubMed ID: 15132437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]